NYSEMKT: NRXS
Neuraxis Inc Stock Ownership - Who owns Neuraxis?

Insider buying vs selling

Have Neuraxis Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gil AharonDirector2026-01-2221,598$4.63
$100.00kBuy
Kristin A. FergeDirector2026-01-2221,598$4.63
$100.00kBuy
Gil AharonDirector2025-12-23286,138$3.52
$1.01MBuy
Masimo Corp10% Owner2025-07-01289,779$2.25
$652.00kSell
Brian Hannasch10% Owner2025-07-01355,556$2.25
$800.00kBuy
Masimo Corp10% Owner2025-07-01531,548$2.25
$1.20MSell
Brian Hannasch10% Owner2025-04-2118,065$1.73
$31.25kBuy

1 of 1

NRXS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRXS insiders and whales buy or sell their stock.

NRXS Shareholders

What type of owners hold Neuraxis Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Brian Hannasch10.62%1,131,522$4.79MInsider
Christopher Robin Brown7.44%792,837$3.35MInsider
Gil Aharon5.57%593,874$2.51MInsider
Gary Merril Peterson4.86%518,120$2.19MInsider
Aigh Capital Management LLC3.75%400,000$1.69MInstitution
Parsons Capital Management Inc1.10%116,726$493.75kInstitution
Vanguard Group Inc0.67%71,632$303.00kInstitution
Geode Capital Management LLC0.48%50,836$215.04kInstitution
Kristin A. Ferge0.34%35,938$152.02kInsider
Citadel Advisors LLC0.33%35,627$150.70kInstitution

1 of 3

NRXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXS7.60%29.65%Net SellingNet Buying
LITS27.59%50.39%Net SellingNet Selling
KZR20.97%79.03%Net Selling
ANEB40.89%59.11%
IBIO9.37%90.63%

Neuraxis Stock Ownership FAQ

Who owns Neuraxis?

Neuraxis (NYSEMKT: NRXS) is owned by 7.60% institutional shareholders, 29.65% Neuraxis insiders, and 62.75% retail investors. Brian Hannasch is the largest individual Neuraxis shareholder, owning 1.13M shares representing 10.62% of the company. Brian Hannasch's Neuraxis shares are currently valued at $4.79M.

If you're new to stock investing, here's how to buy Neuraxis stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.